0001571049-17-004291.txt : 20170501
0001571049-17-004291.hdr.sgml : 20170501
20170501210434
ACCESSION NUMBER: 0001571049-17-004291
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20170427
FILED AS OF DATE: 20170501
DATE AS OF CHANGE: 20170501
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: PHIBRO ANIMAL HEALTH CORP
CENTRAL INDEX KEY: 0001069899
STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834]
IRS NUMBER: 131840497
STATE OF INCORPORATION: DE
FISCAL YEAR END: 0630
BUSINESS ADDRESS:
STREET 1: GLENPOINTE CENTRE EAST, 3RD FLOOR
STREET 2: 300 FRANK W. BURR BLVD., SUITE 21
CITY: TEANECK
STATE: NJ
ZIP: 07666
BUSINESS PHONE: 201-329-7300
MAIL ADDRESS:
STREET 1: GLENPOINTE CENTRE EAST, 3RD FLOOR
STREET 2: 300 FRANK W. BURR BLVD., SUITE 21
CITY: TEANECK
STATE: NJ
ZIP: 07666
FORMER COMPANY:
FORMER CONFORMED NAME: PHILIPP BROTHERS CHEMICALS INC
DATE OF NAME CHANGE: 19980908
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Miller Larry Lee
CENTRAL INDEX KEY: 0001603584
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-36410
FILM NUMBER: 17802661
MAIL ADDRESS:
STREET 1: 8 HAZELWOOD COURT
CITY: WARREN
STATE: NJ
ZIP: 07059
FORMER NAME:
FORMER CONFORMED NAME: Miller Larry Lars
DATE OF NAME CHANGE: 20140325
4
1
t1701363_f4.xml
OWNERSHIP DOCUMENT
X0306
4
2017-04-27
0
0001069899
PHIBRO ANIMAL HEALTH CORP
PAHC
0001603584
Miller Larry Lee
300 FRANK W. BURR BLVD., STE 21
TEANECK
NJ
07666-6712
0
1
0
0
Chief Operating Officer
Class A Common Stock
2017-04-27
4
M
0
4397
11.83
A
4397
D
Class A Common Stock
2017-04-27
4
S
0
4397
30.02
D
0
D
Class A Common Stock
2017-05-01
4
M
0
10383
11.83
A
10383
D
Class A Common Stock
2017-05-01
4
S
0
10383
30.17
D
0
D
Option to purchase Class A Common Stock
11.83
2017-04-27
4
M
0
4397
0
D
2013-04-29
2019-02-28
Class A Common Stock
4397
258661
D
Option to purchase Class A Common Stock
11.83
2017-05-01
4
M
0
10383
0
D
2013-04-29
2019-02-28
Class A Common Stock
10383
248278
D
The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on June 14, 2016.
The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $30.00 to $30.13, inclusive.
The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $30.00 to $30.45, inclusive
/s/ Thomas G. Dagger, as Attorney-in-Fact for Larry L. Miller
2017-05-01